Logo image of RXST

RXSIGHT INC (RXST) Stock Overview

NASDAQ:RXST - US78349D1072 - Common Stock

9.04 USD
-0.11 (-1.2%)
Last: 8/29/2025, 8:00:02 PM
9 USD
-0.04 (-0.44%)
After Hours: 8/29/2025, 8:00:02 PM

RXST Key Statistics, Chart & Performance

Key Statistics
52 Week High57.53
52 Week Low6.32
Market Cap369.92M
Shares40.92M
Float38.41M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.8
PEN/A
Fwd PEN/A
Earnings (Next)11-07 2025-11-07/amc
IPO07-30 2021-07-30
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


RXST short term performance overview.The bars show the price performance of RXST in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

RXST long term performance overview.The bars show the price performance of RXST in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of RXST is 9.04 USD. In the past month the price increased by 15.9%. In the past year, price decreased by -83.97%.

RXSIGHT INC / RXST Daily stock chart

RXST Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 26.43 39.88B
COO COOPER COS INC/THE 16.76 13.45B
SOLV SOLVENTUM CORP 12.02 12.67B
ALGN ALIGN TECHNOLOGY INC 15.09 10.29B
MMSI MERIT MEDICAL SYSTEMS INC 24.74 5.36B
BLCO BAUSCH + LOMB CORP 34.83 5.18B
LNTH LANTHEUS HOLDINGS INC 8.59 3.73B
ICUI ICU MEDICAL INC 16.98 3.15B
XRAY DENTSPLY SIRONA INC 8.36 2.85B
HAE HAEMONETICS CORP/MASS 11.73 2.63B
UFPT UFP TECHNOLOGIES INC 24.35 1.62B
STAA STAAR SURGICAL CO N/A 1.35B

About RXST

Company Profile

RXST logo image RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Company Info

RXSIGHT INC

100 Columbia Street, Suite 120

Aliso Viejo CALIFORNIA US

CEO: Ron Kurtz

Employees: 498

RXST Company Website

RXST Investor Relations

Phone: 19495217822

RXSIGHT INC / RXST FAQ

What is the stock price of RXSIGHT INC today?

The current stock price of RXST is 9.04 USD. The price decreased by -1.2% in the last trading session.


What is the ticker symbol for RXSIGHT INC stock?

The exchange symbol of RXSIGHT INC is RXST and it is listed on the Nasdaq exchange.


On which exchange is RXST stock listed?

RXST stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for RXSIGHT INC stock?

16 analysts have analysed RXST and the average price target is 9.18 USD. This implies a price increase of 1.55% is expected in the next year compared to the current price of 9.04. Check the RXSIGHT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is RXSIGHT INC worth?

RXSIGHT INC (RXST) has a market capitalization of 369.92M USD. This makes RXST a Small Cap stock.


How many employees does RXSIGHT INC have?

RXSIGHT INC (RXST) currently has 498 employees.


What are the support and resistance levels for RXSIGHT INC (RXST) stock?

RXSIGHT INC (RXST) has a support level at 8.49 and a resistance level at 9.23. Check the full technical report for a detailed analysis of RXST support and resistance levels.


Is RXSIGHT INC (RXST) expected to grow?

The Revenue of RXSIGHT INC (RXST) is expected to decline by -10.36% in the next year. Check the estimates tab for more information on the RXST EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy RXSIGHT INC (RXST) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RXSIGHT INC (RXST) stock pay dividends?

RXST does not pay a dividend.


When does RXSIGHT INC (RXST) report earnings?

RXSIGHT INC (RXST) will report earnings on 2025-11-07, after the market close.


What is the Price/Earnings (PE) ratio of RXSIGHT INC (RXST)?

RXSIGHT INC (RXST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.8).


What is the Short Interest ratio of RXSIGHT INC (RXST) stock?

The outstanding short interest for RXSIGHT INC (RXST) is 16.31% of its float. Check the ownership tab for more information on the RXST short interest.


RXST Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to RXST. When comparing the yearly performance of all stocks, RXST is a bad performer in the overall market: 98.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RXST Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to RXST. The financial health of RXST is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RXST Financial Highlights

Over the last trailing twelve months RXST reported a non-GAAP Earnings per Share(EPS) of -0.8. The EPS increased by 18.37% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -10.44%
ROE -11.6%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-81.25%
Sales Q2Q%-3.58%
EPS 1Y (TTM)18.37%
Revenue 1Y (TTM)27.68%

RXST Forecast & Estimates

16 analysts have analysed RXST and the average price target is 9.18 USD. This implies a price increase of 1.55% is expected in the next year compared to the current price of 9.04.

For the next year, analysts expect an EPS growth of -74.25% and a revenue growth -10.36% for RXST


Analysts
Analysts52.5
Price Target9.18 (1.55%)
EPS Next Y-74.25%
Revenue Next Year-10.36%

RXST Ownership

Ownership
Inst Owners98.06%
Ins Owners5.51%
Short Float %16.31%
Short Ratio4.46